Controversial Crossroads: Treatment for Pulmonary Embolism Recorded Presentation
This presentation will review the classification and risk stratification in patients with pulmonary embolism, as well as evaluate different treatment modalities for thrombolytic dosing in pulmonary embolism.
If you attended Controversial Crossroads: Treatment for Pulmonary Embolism Session on Sept 17, 2024, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
Target Audience
This course is intended for Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals
Learning Objectives
At the end of this session, learners should be able to:
- Classify the severity of pulmonary embolism
- Recall current guidelines for the use of thrombolytics in pulmonary embolism
- Evaluate different treatment modalities for thrombolytic dosing in pulmonary embolism
- Develop an evidence based thrombolytic treatment plan for a patient with a pulmonary embolism
Faculty
Alex Nunez, PharmD, PGY2 Critical Care Pharmacy Resident – Aurora Health Care Metro, Inc.
Disclosure
The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.
Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this enduring activity for a maximum of 1.00 ANCC contact hours/APRN pharmacological hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this enduring activity for a maximum 1.00 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 1.00 AttendanceAttendance Credit
- 1.00 Approved AMA PRA Category 1 Credit™
- 1.00 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
- 1.00 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Price
If you attended Controversial Crossroads: Treatment for Pulmonary Embolism Session on Sept 17, 2024, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
This course is available to Advocate Aurora providers (employed and independent) and caregivers only. Click “Take Course” to register for this program.
If you have any questions, please contact the IPCE Office at cme@aah.org